SavedAdd your journal

Journals / Turkish Journal of Obstetrics and Gynecology / 2019 / Cilt: 16 - Sayı: 4

The prevalence of uterine anomalies in infertile patients with polycystic ovary syndrome: A retrospective study in a tertiary center in Southeastern Turkey

İnfertil polikistik over sendromu hastalarında uterus anomalilerinin prevalansı: Türkiye’nin Güneydoğusunda bulunan üçüncü basamak bir merkezde retrospektif çalışma

Serhat EGE
Nurullah PEKER
Muhammed Hanifi BADEMKIRAN
Pages
224–227
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

A statistically significant difference was found between the two groups (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the prevalence of uterine anomalies in infertile patients with polycystic ovary syndrome (PCOS) admitted to our tertiary hospital inSoutheastern Turkey.Materials and Methods: The files of 3033 patients with infertility who presented to the infertility polyclinics were retrospectively analyzed, and uterine anomalieswere detected in 131 patients.
📊
Key Findings & Data:Seven hundred ten of these patients were evaluated as having PCOS, 55 of whom had uterine anomalies.
💡
Conclusion & Impact:A statistically significant difference was found between the two groups (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the prevalence of uterine anomalies in infertile patients with polycystic ovary syndrome (PCOS) admitted to our tertiary hospital inSoutheastern Turkey.Materials and Methods: The files of 3033 patients with infertility who presented to the infertility polyclinics were retrospectively analyzed, and uterine anomalieswere detected in 131 patients. Seven hundred ten of these patients were evaluated as having PCOS, 55 of whom had uterine anomalies. Patients with PCOS werealso divided into two subgroups as those with primary and secondary infertility.Results: Of the 3033 patients with infertility who were evaluated, 57 (8%) of 710 infertile patients with PCOS, and 74 (3%) of 2323 non-PCOS patients withinfertility had uterine anomalies. A statistically significant difference was found between the two groups (p

Özet

Amaç: Bu çalışmada, polikliniğimize başvuran infertil polikistik over sendromu (PKOS) hastalarında, uterus anomalilerinin prevalansı değerlendirildi. Gereç ve Yöntemler: Şubat 2017 ve Mayıs 2019 tarihleri arasında Gazi Yaşargil Eğitim ve Araştırma Hastanesi İnfertilite polikliniğine başvuran 3.033 infertil hastanın dosyaları geriye dönük olarak incelendi ve 131 hastada uterus anomalisi saptandı. Yedi yüz on hasta PKOS olarak değerlendirildi ve 57’sinde uterus anomalisi vardı. Ayrıca PKOS hastaları primer ve sekonder olarak 2 alt gruba ayrıldı. Bulgular: Üç bin otuz üç infertil hasta değerlendirildi. Yedi yüz on infertil PKOS hastanın 57’sinde (%8) ve PKOS olmayan 2,323 infertil hastanın 74’ünde (%3) uterus anomalisi saptandı. İki grup arasında istatistiksel olarak anlamlı bir fark bulundu (p

🔖

Cite This Article

EGE, S., PEKER, N., BADEMKIRAN, M. H. (2022). The prevalence of uterine anomalies in infertile patients with polycystic ovary syndrome: A retrospective study in a tertiary center in Southeastern Turkey. Turkish Journal of Obstetrics and Gynecology, Cilt: 16 - Sayı: 4, 224–227. https://ajindex.com/articles/612997

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Azziz R, Woods K, Reyna R, Key T, Knochenhauer E, Yildiz B. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-9
  2. Bednarska S, Siejka A. The pathogenesis and treatment of polycystic ovary syndrome: What’s new? Adv Clin Exp Med 2017;26:359-67
  3. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update 2001;7:161-74
  4. Chan Y, Jayaprakasan K, Tan A, Thornton J. Coomarasamy A, RaineFenning N. Reproductive outcomes in women with congenital uterine anomalies: A systematic review. Ultrasound Obstet Gynecol 2011;38:371-82
  5. Troiano RN, McCarthy SM. Müllerian duct anomalies: Imaging and clinical issues. Radiology 2004;233:19-34
  6. Azziz R, Tarlatzis R, Dunaif A. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Fertil Steril 2004;81:19-25
  7. Buttram V, Gomel V, Siegler A, DeCherney A, Gibbons W, March C. The American Fertility Society classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Mullerian anomalies and intrauterine adhesions. Fertil Steril 1988;49:944-55
  8. Ghi T, Casadio P, Kuleva M, Perrone A, Savelli L, Giunchi S, et al. Accuracy of three-dimensional ultrasound in diagnosis and classification of congenital uterine anomalies. Fertil Steril 2009;92:808-13
  9. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update 2008;14:415-29
  10. Lee DM, Osathanondh R, Yeh J. Localization of Bcl-2 in the human fetal mullerian tract. Fertil Steril 1998;70:135-40
  11. Pellatt L, Rice S, Mason HD. Anti-Müllerian hormone and polycystic ovary syndrome: A mountain too high? Reproduction 2010;139:825-33
  12. Woo HY, Kim KH, Rhee EJ, Park H, Lee MK. Differences of the association of anti-Müllerian hormone with clinical or biochemical characteristics between women with and without polycystic ovary syndrome. Endocr J 2012;59:781-90
  13. Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D. Anti-Müllerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: Relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab 2